methscopolamine bromide

Key facts

INN

methscopolamine bromide

Brand

METHSCOPOLAMINE BROMIDE

Route

ORAL

Formulation

TABLET

Related patents

patent

US 12162861

Dopamine D3 receptor selective antagonists/partial agonists; method of making; a

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12145922

Selective D3 dopamine receptor agonists and methods of their use

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12102640

Use of dopamine and serotonin receptor antagonists for treatment in a subject wi

Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12097196

Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11634404

Selective D3 dopamine receptor agonists and methods of their use

Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11337971

Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11299476

Dopamine D3 receptor selective antagonists/partial agonists; method of making; a

Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11261461

Methods and compositions for selective generation of dopaminergic precursors

Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is methscopolamine bromide?

methscopolamine bromide (METHSCOPOLAMINE BROMIDE), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for methscopolamine bromide?

METHSCOPOLAMINE BROMIDE is a marketed brand name for methscopolamine bromide. Check FDA Drugs@FDA for the current US label holder.